dc.contributor.author | de la Rubia Ortí, José Enrique | |
dc.contributor.author | Platero Armero, José Luis | |
dc.contributor.author | Sanchis-Sanchis, Claudia Emmanuela | |
dc.contributor.author | Sancho Castillo, Sandra | |
dc.contributor.author | Salazar, Alejandro | |
dc.contributor.author | Caplliure Llopis, Jordi | |
dc.contributor.author | Navarro Illana, Esther | |
dc.contributor.author | Barrios Pitarque, Carlos | |
dc.contributor.author | Escribá-Apeluz, Jesús | |
dc.contributor.author | Benlloch García, María | |
dc.date.accessioned | 2022-07-14T07:52:10Z | |
dc.date.available | 2022-07-14T07:52:10Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12466/2399 | |
dc.description.abstract | Background: One of the pathogenic mechanisms of ALS disease is perturbed energy
metabolism particularly glucose metabolism. Given the substantial difference in the severity and
the prognosis of the disease, depending on whether it has a bulbar or spinal onset, the aim of the
study was to determine metabolic differences between both types of ALS, as well as the possible
relationship with muscle function. Materials and Methods: A descriptive, analytical, quantitative,
and transversal study was carried out in hospitals and Primary Care centers in the region of Valencia,
Spain. Fasting glucose and alkaline phosphatase (AP) levels in venous blood, muscle percentage, fat
percentage, muscle strength (MRC scale), and functional capacity (Barthel Index) were measured in
31 patients diagnosed with ALS (20 with spinal onset ALS and 11 with bulbar onset ALS). A healthy
control of 29 people was included. Results: No significant differences were observed in blood AP and
glucose levels between spinal onset and bulbar onset ALS patients. However, a significant positive
correlation was observed between the mean values of both substances in patients with spinal onset
ALS. Moreover, a lower percentage of muscle mass and a higher percentage of fat mass were also
seen in spinal ALS patients, who also presented lower muscle strength and lower functional capacity.
Conclusion: The results of this study seem to point to a possible difference in the peripheral use of
glucose between patients with bulbar onset ALS and spinal onset ALS, who appear to have possible
insulin resistance. These metabolic differences could explain the lower muscle percentage and lower
muscular function in spinal onset ALS patients, although further studies are required. | en |
dc.language.iso | eng | es |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.title | Muscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It Depend on Peripheral Glucose? | en |
dc.type | article | es |
dc.description.discipline | Enfermería | es |
dc.identifier.doi | 10.3390/jcm10081582 | |
dc.issue.number | 1582 | es |
dc.journal.title | Journal of Clinical Medicine | en |
dc.page.initial | 1 | es |
dc.page.final | 13 | es |
dc.rights.accessRights | openAccess | es |
dc.subject.keyword | Diseases | en |
dc.subject.keyword | Glucose | en |
dc.subject.keyword | Metabolism | en |
dc.subject.keyword | Amyotrophic Lateral Sclerosis | en |
dc.subject.keyword | Hospitals | en |
dc.volume.number | 10 | es |
dc.subject.unesco | 32 Ciencias Médicas | es |